Publication

Application

Priority

CH 140497 A 19970610

EP 9803427 W 19980608

Abstract (en)

[origin: WO9856772A1] The invention relates to the novel modification A or A' of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of formula (I), its use for the treatment of epilepsy, and pharmaceutical preparations comprising this crystal modification.

2013-05-29[REG GB SPCX] CORRECTION OF AN ERRATUM IN THE GAZETTE CONCERNING A SUPPLEMENTARY PROTECTION CERTIFICATE

- Free text: ERRATUM OF SPC/GB07/041 GRANTED ON 1 SEPTEMBER 2008. THE ERRATUM APPEARING IN THE JOURNAL NO. 6236 ON 26 NOVEMBER 2008 CONTAINED AN ERROR. A CORRECTION TO THE SPC FILED ON SPC/GB07/041 WAS ALLOWED ON 10 NOVEMBER 2008 TO SHOW THAT BASIC PATENT TO BE EP0994863 AND NOT EP0994864 AS PREVIOUSLY SHOWN.